Share Email Print

Proceedings Paper

In vitro study for photodynamic therapy using Fotolon in glioma treatment
Author(s): Sara Abdel Hamid; Wolfgang Zimmermann; Dirk Huettenberger; Rainer Wittig; Mahmoud Abdel Kader; Herbert Stepp
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Several forms of Chlorin e6 and its derivatives are reported as efficient photosensitizers (PS) studied in Photodynamic Therapy (PDT) for oncologic applications. Fotolon® is a pure form of Chlorin e6 trisodium salt developed by Apocare Pharma.

Paper Details

Date Published: 15 July 2015
PDF: 13 pages
Proc. SPIE 9542, Medical Laser Applications and Laser-Tissue Interactions VII, 95420B (15 July 2015); doi: 10.1117/12.2183884
Show Author Affiliations
Sara Abdel Hamid, The German Univ. in Cairo (Egypt)
Wolfgang Zimmermann, Ludwig-Maximilians-Univ. München (Germany)
Dirk Huettenberger, Apocare Pharma GmbH (Germany)
Rainer Wittig, Ulm Univ. (Germany)
Mahmoud Abdel Kader, The German Univ. in Cairo (Egypt)
Herbert Stepp, Klinikum der Univ. München (Germany)

Published in SPIE Proceedings Vol. 9542:
Medical Laser Applications and Laser-Tissue Interactions VII
Lothar D. Lilge; Ronald Sroka, Editor(s)

© SPIE. Terms of Use
Back to Top